Treatment of obesity, metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, Alzheimer's disease and inflammatory bowel disease using at least one bacterial strain of Prevotella
A product for use in the treatment of obesity, metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, Alzheimer's disease and inflammatory bowel disease comprising at least one bacterial strain isolated from Prevotellaceae species, where the strain is selected from the group consisting of Prevotella copri and Prevotella ruminicola.Un producto para su uso en el tratamiento de obesidad, síndrome metabólico, diabetes tipo 2, enfermedades cardiovasculares, demencia, enfermedad de Alzheimer y enfermedad inflamatoria intestinal que comprende al menos una cepa bacteriana aislada a partir de las especies Prevotellaceae, donde la cepa se selecciona de entre el grupo que consiste en Prevotella copri y Prevotella ruminicola.
